Skip to main content
Clinical Trials/NCT06207448
NCT06207448
Completed
N/A

Deep Infiltrating Endometriosis : Laparoscopic Nerve-sparing Surgery and Use of Neutral Argon Plasma

University Hospital, Strasbourg, France1 site in 1 country1 target enrollmentApril 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Endometriosis Ovary
Sponsor
University Hospital, Strasbourg, France
Enrollment
1
Locations
1
Primary Endpoint
To retrospectively describe the minimally invasive management of deep pelvic endometriosis using nerve-sparing surgery and the use of neutral argon plasma for extensive endometriotic lesions by laparoscopy
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Medical treatment of endometriosis has a suspensive and sometimes incomplete effect on the symptoms, making surgical treatment necessary. The aim of surgical treatment of deep endometriosis is to restore normal anatomy and functional integrity. Resection of deep endometriosis lesions is recommended to relieve pain, gynecological and digestive symptoms, but rarely urinary disorders. Nerve-sparing surgery, when feasible, reduces post-operative dysuria by sparing the lower hypogastric plexus.

The major limitations of these surgical procedures are the experience of the surgeon and the extent of the disease. Acquiring the surgical techniques and skills necessary to carry out these types of procedures is essential to providing optimal patient care.

Registry
clinicaltrials.gov
Start Date
April 1, 2022
End Date
June 6, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult woman (≥18 years old)
  • Patient who benefited from treatment by nerve-sparing surgery and the use of neutral argon plasma in the context of symptomatic deep pelvic endometriosis at the Strasbourg University Hospital during 2021
  • Patient who did not express, after information, the reuse of her data for the purposes of this research.

Exclusion Criteria

  • Patient who expressed her opposition to participating in the study
  • Patient under legal protection, under guardianship or under curatorship

Outcomes

Primary Outcomes

To retrospectively describe the minimally invasive management of deep pelvic endometriosis using nerve-sparing surgery and the use of neutral argon plasma for extensive endometriotic lesions by laparoscopy

Time Frame: up to 2 months

Study Sites (1)

Loading locations...

Similar Trials